Dr. Erica Stringer-Reasor shares her expertise on precision medicine advancements in breast cancer

Dr. Erica Stringer-Reasor shares her expertise on precision medicine advancements in breast cancer

Publication date: Oct 08, 2019

In honor of breast cancer awareness month, Dr. Erica Stringer-Reasor joins us to discuss how breast cancer has led the way in the adoption of precision medicine. Dr. Stringer-Reasor is an expert in the field of breast cancer, a fast-rising star in cancer research and Assistant Professor of Hematology Oncology at the University of Alabama, Birmingham.

Concepts Keywords
Air Advanced breast cancer
Alabama Hereditary genes
Angelina Jolie Chronic disease
Auburn University Lakes days disease
Austin Metastatic breast cancer
Biopsies Patient centered cancer
Biopsy Invasive breast cancer
Birmingham Express tumors
Blood Hereditary cancer syndrome
Breast Upfront diseases
Breast Cancer Incurable disease
Cancer Colon cancers
Castor Prostate cancers
Chronic Disease Disease
Clinical Trials Tumors
Colon Advanced cancers
Community Leagues Burn
Complement Breast cancers
Direction Finding Ovarian cancer
DNA Tumor
Esophagus Cancers
Estrogen Satellite clinics
Florida Chemical genetics
Football Cancer care
Gastrointestinal Gastrointestinal systems
Genetic Health
Genetic Mutations RTT
Genetic Test Medicine
Genetics Oncology
Georgia Breast cancer awareness
Google Triple-negative breast cancer
Growth Factor Metastatic breast cancer
Hematology Treatment of cancer
Homo Prostate cancer
Hormone Ovarian cancer
Hormones Pharmacogenetics
Hospital Gene expression
Ido
Ing
ISS
Jeans
Jerome
Jos
Komen
Madison
Mako
Malvern
Metastatic
Metastatic Breast Cancer
Mutation
Oncologist
Overproduction
Patient Advocacy
Patient Centered Care
Pharmacogenetics
Physician
Podcast
Precision Medicine
Progesterone
Prognosis
Prostate
Receptor
Relapse
Ring
Satellite
Star
Stomach
Street
Syndrome
Tamoxifen
Targeted Therapies
Targeted Therapy
Texas
Tide
Triple Negative
Tumor
Twitter
United States
War

Semantics

Type Source Name
disease MESH breast cancer
disease DOID breast cancer
pathway BSID Breast cancer
gene UNIPROT STAR
gene UNIPROT GUCY2C
disease MESH cancer
disease DOID cancer
gene UNIPROT TRAIP
gene UNIPROT LRRFIP1
disease DOID face
gene UNIPROT ELOVL6
gene UNIPROT FANCE
drug DRUGBANK Coenzyme M
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Aspartame
drug DRUGBANK Tamoxifen
gene UNIPROT IMPACT
gene UNIPROT BAD
pathway BSID Gene Expression
gene UNIPROT YES1
gene UNIPROT NCKIPSD
gene UNIPROT SGSM3
disease MESH relapse
disease MESH chronic disease
gene UNIPROT DBF4
gene UNIPROT ARSK
disease MESH estrogen
drug DRUGBANK Progesterone
gene UNIPROT IDO1
disease MESH growth
gene UNIPROT CHL1
disease MESH triple negative breast cancer
drug DRUGBANK Tropicamide
gene UNIPROT LAT2
disease MESH community
drug DRUGBANK Medical air
disease MESH risk factors
disease MESH hereditary cancer syndrome
disease MESH ovarian cancer
disease DOID ovarian cancer
disease MESH prostate cancers
disease MESH colon cancers
drug DRUGBANK Water
gene UNIPROT RXFP2
disease MESH men
gene UNIPROT LARGE1

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *